2021 August

PD-MitoQUANT research presented at upcoming Neuroscience Ireland 2021 meeting

pdmq_admin2021-09-07T11:22:07+01:00August 26th, 2021|News|

PD-MitoQUANT research will be presented by postdoctoral researcher Dr Niraj Khemka of the RCSI by way of a poster at the virtual Neuroscience Ireland 2021 meeting. The poster entitled "Multi-omics profiling of fibril-induced alpha-synuclein aggregation in primary neurons as model for Parkinson’s disease" will be presented on September 9th and 10th. The meeting programme features two poster sessions, four themed symposia, three plenary lectures and the Tom Connor Distinguished Investigator Award Prize Lecture.

The August 2021 PD-MitoQUANT newsletter is out!

pdmq_admin2021-08-12T10:44:03+01:00August 12th, 2021|News, Partner in the Spotlight|

Just out! Read the latest PD-MitoQUANT news in our just-published August 2021 newsletter. Coordinator Prof. Jochen Prehn provides an overview of the progress-to-date. Learn about three of our partners and their roles through our spotlight pieces on the University College London, the Centre National de la Recherche Scientifique and the Neuroscience Institute of the National Research Council (CNR). There's a dissemination round-up and much more! Download the August PD-MitoQUANT newsletter here.

Dr Sinéad O’Sullivan, DZNE presents at August 12th NeuroConnect meeting

pdmq_admin2021-08-09T12:20:59+01:00August 9th, 2021|News, Partner in the Spotlight|

Dr Sinéad O'Sullivan, Humboldt Fellow at the German Center for Neurodegenerative Diseases, the DZNE, will present PD-MitoQUANT findings and her research at the next NeuroConnect meeting, August 12th at 4:00 PM Irish Time. Dr O'Sullivan will present her research on alpha-synuclein induced mitochondrial dysfunction and the role of glial cells in Parkinson's disease. Sinéad's talk entitled 'Modelling alpha-synuclein pathology in vivo' will also include an overview of the pre-clinical models used in the lab: AAV human alpha-synuclein overexpression in the substantia [...]

CNRS Research Director Ronald Melki co-authors comprehensive Alpha-synuclein review in Nature

pdmq_admin2024-06-12T18:24:39+01:00August 5th, 2021|News, Partner in the Spotlight|

Prof Ronald Melki, CNRS Prof. Ronald Melki, Research Director at the CNRS co-authored with several Parkinson's research experts a recent review 'Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease'. The paper's authors are Luis M. A. Oliveira, Thomas Gasser, Robert Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal A. Lashuel, David Sulzer, Kostas Vekrellis, Glenda M. Halliday, Julianna J. Tomlinson, Michael Schlossmacher, Poul Henning Jensen, Julia Schulze-Hentrich, Olaf Riess, Warren D. Hirst, Omar El-Agnaf, Brit [...]

Prof. Ronald Melki, CNRS will speak at Young Scientist Symposium on Protein Quality

pdmq_admin2021-08-09T15:29:06+01:00August 3rd, 2021|News|

Professor Ronald Melki, CNRS will deliver a plenary talk in the Young Scientist Symposium on Protein Quality, September 23rd and 24th. The two-day online meeting aims to provide young scientists (postdocs and PhD students) an attractive and interactive platform to present and discuss their current work with everyone in the field of protein quality control. If you are interested in presenting your work with either a short talk or a flash talk or want to attend this exciting symposium, then [...]